POLYTECH Health & Aesthetics Unveils Innovative Microthane® Process for Breast Implants

POLYTECH Health & Aesthetics Launches Microthane® with Advanced Manufacturing Process



In a significant development in the world of medical technology, POLYTECH Health & Aesthetics has announced the phased rollout of Microthane®, a new version of their popular breast implants. This announcement coincides with the company’s 40-year anniversary, underscoring its commitment to quality and innovation in the field of breast aesthetics and reconstruction.

Continuous Innovation and Commitment to Quality


With a pioneering spirit, POLYTECH has always prioritized the enhancement of breast implant technologies, utilizing a blend of clinical experience, in-house research, and collaboration with the surgical community. The Microthane® implants represent a culmination of these efforts, embodying the company’s philosophy of continuous improvement. The innovation lies in its updated proprietary manufacturing process, which is currently under European patent application EP26184379.1, dated June 10, 2026.

“Innovation at POLYTECH is built on continuous research,” stated Prof. Dr. Karsten Hemmrich, the CEO of POLYTECH. This ethos is reflected in the Microthane® implants, which preserve the clinical benefits that have made them a favored choice for both aesthetic and reconstructive surgeries while introducing a cutting-edge manufacturing process.

Enhanced Design Features


The updated process enhances several key design features. It ensures a flat, patch-free posterior surface and smooth edges, factors that are critical for patient comfort and aesthetic appeal. The Microthane® implants maintain the characteristics that surgeons and patients have come to appreciate over years of use, thereby reaffirming POLYTECH's commitment to excellence in breast implant quality.

Phased Market Introduction


The new Microthane® implants will be introduced in selected markets, with ongoing plans for regional rollout based on production capabilities and compliance with regulatory requirements. Healthcare professionals interested in utilizing Microthane® are encouraged to reach out to their local POLYTECH representatives for specifics regarding product availability in their respective markets.

About POLYTECH Health & Aesthetics


POLYTECH Health & Aesthetics GmbH is a leader in the medical technology sector, with over four decades of experience in the development of breast aesthetics, reconstruction, and body contouring solutions. With a presence in over 90 countries worldwide, POLYTECH is revered for its dedication to quality and innovation. The company is committed to supporting clinical practices with top-of-the-line products that evolve in line with the latest clinical research and best practices in aesthetic and reconstructive surgery. Every product is developed and manufactured at POLYTECH's headquarters in Dieburg, Germany, ensuring the highest standards of quality and performance.

Conclusion


As POLYTECH continues to lead the way in enhancing breast implant technologies, the introduction of Microthane® signifies another step forward in its unwavering journey toward innovation, patient safety, and exceptional clinical outcomes. With a solid foundation of experience and cutting-edge technology, POLYTECH sets a new standard for breast aesthetic solutions.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.